Biochemical properties of the endothelium‐derived growth factor: Comparision to other growth factors
- 1 March 1983
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 114 (3) , 339-345
- https://doi.org/10.1002/jcp.1041140313
Abstract
Cultured bovine aortic endothelial cells (BAEC) can be maintained at saturation density for several weeks in the absence of serum. These cells retain viability and normal culture morphology, and continuously produce a growth factor for mesenchymally derived cells–the endothelium‐derived growth factor (EDGF). The amount and specific activity of EDGF that is produced by BAEC under serum‐free conditions remains constant for weeks. The levels of EDGF produced under these serum‐free conditions is equivalent to levels produced in medium containing 5% plasma‐derived serum. EDGF has been found to be trypsin sensitive, acetone and ammonium sulfate precipitable, and resistant to heat and sodium dodecyl sulfate treatment. Gel filtration on Sephacryl S‐200 in the presence of formic acid (1%) yields two major peaks of activity corresponding to proteins of apparent molecular weights of approximately 24,000 and 14,000 daltons. This chromatographic step affords a ten‐to 12‐fold purification with a combined recovery of greater than 85%. Unlike brain or pituitary fibroblast growth factor, EDGF activity is destroyed by dithiothreitol or periodic acid. EDGF is not a somatomedin since it exhibits no detectable sulfation activity in a porcine cartilage assay. EDGF is not inhibited by antiserum to epidermal growth factor and is capable of stimulating DNA synthesis in a 3T3 variant cell line that is nonresponsive to and lacks receptors for epidermal growth factor. The majority of EDGF activity does not behave like the platelet‐derived growth factor during ion exchange chromatography. Antisera prepared in rabbits and in mice to human platelet‐derived growth factor has little effect on bivine or human EDGF activity. These biochemical and immunological properties of EDGF indicate that it is distinct from several other well‐characterized polypeptide growth factors.This publication has 30 references indexed in Scilit:
- Human monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and concanavalin ACell, 1981
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthThe Journal of cell biology, 1981
- Microcarrier culture of vascular endothelial cells on solid plastic beadsExperimental Cell Research, 1981
- Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: Relation to human somatomedins and insulinJournal of Supramolecular Structure and Cellular Biochemistry, 1981
- Chemical and biological properties of a growth factor from human‐cultured osteosarcoma cells: Resemblance with platelet‐derived growth factorJournal of Cellular Physiology, 1980
- An endothelial cell-derived growth factor.The Journal of cell biology, 1980
- Sarcoma growth factor (SGF): Specific binding to epidermal growth factor (EGF) membrane receptorsJournal of Cellular Physiology, 1980
- Purification and Characterization of Multiplication‐Stimulating ActivityEuropean Journal of Biochemistry, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication‐stimulating activity for embryo fibroblastsJournal of Cellular Physiology, 1973